Secondly, a common amino-acid variant, R462Q, which was previously found to be associated with prostate cancer risk (Casey et al, 2002), was proven to reduce the affinity of RNase L to form catalytically active dimers (Xiang et al, 2003). Here, RNASEL is linked to prostate carcinoma.